Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.93 USD | +5.46% | +3.76% | -44.89% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.39M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -21M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.43
x | P/E ratio 2025 * |
-0.39
x | Employees | 17 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.41% |
Latest transcript on TRACON Pharmaceuticals, Inc.
1 day | +5.46% | ||
1 week | +3.76% | ||
Current month | +11.56% | ||
1 month | -35.88% | ||
3 months | -48.64% | ||
6 months | -58.10% | ||
Current year | -44.89% |
Managers | Title | Age | Since |
---|---|---|---|
Charles Theuer
CEO | Chief Executive Officer | 60 | 06-06-30 |
Scott Brown
DFI | Director of Finance/CFO | 43 | 15-07-31 |
James L. Freddo
CTO | Chief Tech/Sci/R&D Officer | 69 | 20-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Mattingly
BRD | Director/Board Member | 66 | 14-12-25 |
Director/Board Member | 54 | 20-03-18 | |
Stephen Worland
BRD | Director/Board Member | 66 | 15-02-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 1.93 | +5.46% | 451,307 |
24-05-09 | 1.83 | +3.98% | 132,599 |
24-05-08 | 1.76 | -3.30% | 114,186 |
24-05-07 | 1.82 | +0.55% | 90,880 |
24-05-06 | 1.81 | -2.69% | 107,223 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.89% | 4.39M | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
-14.40% | 32.25B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B |
- Stock Market
- Equities
- TCON Stock